Literature DB >> 16855629

Megakaryocyte colony-forming unit growth is enhanced by alemtuzumab: in vitro experiments and a case report of acquired amegakaryocytic thrombocytopenic purpura.

M Doubek, Z Korístek, D Havranová, L Smardová, J Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16855629     DOI： 10.1038/sj.leu.2404337

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab.

Authors:  Steven P Treon; Jacob D Soumerai; Zachary R Hunter; Christopher J Patterson; Leukothea Ioakimidis; Brad Kahl; Michael Boxer
Journal:  Blood       Date:  2011-05-12       Impact factor: 22.113

2.  Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case Report.

Authors:  Arya Mariam Roy; Manojna Konda; George K Sidarous; Dinesh Atwal; Steven A Schichman; Anuradha Kunthur
Journal:  Perm J       Date:  2020-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.